Taiwan · Delayed Price · Currency is TWD Prince Pharmaceutical Statistics
Total Valuation
TPEX:6935 has a market cap or net worth of TWD 1.09 billion. The enterprise value is 1.27 billion.
| Market Cap | 1.09B |
| Enterprise Value | 1.27B |
Important Dates
The next estimated earnings date is Monday, August 24, 2026.
| Earnings Date | Aug 24, 2026 |
| Ex-Dividend Date | Jul 1, 2026 |
Share Statistics
TPEX:6935 has 36.61 million shares outstanding. The number of shares has increased by 1.03% in one year.
| Current Share Class | 36.61M |
| Shares Outstanding | 36.61M |
| Shares Change (YoY) | +1.03% |
| Shares Change (QoQ) | +1.65% |
| Owned by Insiders (%) | 10.66% |
| Owned by Institutions (%) | 12.42% |
| Float | 11.67M |
Valuation Ratios
The trailing PE ratio is 8.49.
| PE Ratio | 8.49 |
| Forward PE | n/a |
| PS Ratio | 0.89 |
| PB Ratio | 1.25 |
| P/TBV Ratio | 1.25 |
| P/FCF Ratio | 6.40 |
| P/OCF Ratio | 5.63 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.98, with an EV/FCF ratio of 7.48.
| EV / Earnings | 9.75 |
| EV / Sales | 1.04 |
| EV / EBITDA | 5.98 |
| EV / EBIT | 8.37 |
| EV / FCF | 7.48 |
Financial Position
The company has a current ratio of 1.69, with a Debt / Equity ratio of 0.47.
| Current Ratio | 1.69 |
| Quick Ratio | 0.93 |
| Debt / Equity | 0.47 |
| Debt / EBITDA | 1.92 |
| Debt / FCF | 2.41 |
| Interest Coverage | 16.51 |
Financial Efficiency
Return on equity (ROE) is 16.14% and return on invested capital (ROIC) is 9.20%.
| Return on Equity (ROE) | 16.14% |
| Return on Assets (ROA) | 6.35% |
| Return on Invested Capital (ROIC) | 9.20% |
| Return on Capital Employed (ROCE) | 12.51% |
| Weighted Average Cost of Capital (WACC) | 6.06% |
| Revenue Per Employee | 5.67M |
| Profits Per Employee | 602,421 |
| Employee Count | 216 |
| Asset Turnover | 0.82 |
| Inventory Turnover | 4.06 |
Taxes
In the past 12 months, TPEX:6935 has paid 16.87 million in taxes.
| Income Tax | 16.87M |
| Effective Tax Rate | 11.48% |
Stock Price Statistics
The stock price has increased by +17.76% in the last 52 weeks. The beta is 0.61, so TPEX:6935's price volatility has been lower than the market average.
| Beta (5Y) | 0.61 |
| 52-Week Price Change | +17.76% |
| 50-Day Moving Average | 30.20 |
| 200-Day Moving Average | 30.09 |
| Relative Strength Index (RSI) | 36.33 |
| Average Volume (20 Days) | 38,877 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6935 had revenue of TWD 1.22 billion and earned 130.12 million in profits. Earnings per share was 3.49.
| Revenue | 1.22B |
| Gross Profit | 266.13M |
| Operating Income | 151.54M |
| Pretax Income | 146.99M |
| Net Income | 130.12M |
| EBITDA | 203.35M |
| EBIT | 151.54M |
| Earnings Per Share (EPS) | 3.49 |
Balance Sheet
The company has 224.85 million in cash and 408.28 million in debt, with a net cash position of -183.43 million or -5.01 per share.
| Cash & Cash Equivalents | 224.85M |
| Total Debt | 408.28M |
| Net Cash | -183.43M |
| Net Cash Per Share | -5.01 |
| Equity (Book Value) | 871.54M |
| Book Value Per Share | 23.32 |
| Working Capital | 283.15M |
Cash Flow
In the last 12 months, operating cash flow was 192.77 million and capital expenditures -23.07 million, giving a free cash flow of 169.70 million.
| Operating Cash Flow | 192.77M |
| Capital Expenditures | -23.07M |
| Depreciation & Amortization | 52.74M |
| Net Borrowing | -40.51M |
| Free Cash Flow | 169.70M |
| FCF Per Share | 4.64 |
Margins
Gross margin is 21.73%, with operating and profit margins of 12.37% and 10.62%.
| Gross Margin | 21.73% |
| Operating Margin | 12.37% |
| Pretax Margin | 12.00% |
| Profit Margin | 10.62% |
| EBITDA Margin | 16.60% |
| EBIT Margin | 12.37% |
| FCF Margin | 16.07% |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 1.77%.
| Dividend Per Share | 0.50 |
| Dividend Yield | 1.77% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -1.03% |
| Shareholder Yield | 0.69% |
| Earnings Yield | 11.99% |
| FCF Yield | 15.64% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 8 |